No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
102 |
4. Check minimum number of eventsNone |
102 |
5. Include endpointsNone |
102 |
6. Filter based on genotype QC (FinnGen only) |
102 |
Control definitions (FinnGen only)
- Control exclude
- E4_ENDOGLAND
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E27
- Name in latin
- Hyperfunctio medullae glandulae suprarenalis
Similar endpoints
↥List of similar endpoints to Adrenomedullary hyperfunction based on the number of shared cases.
Similar with more cases:
- Other disorders of adrenal gland
- Exclusions for E4_PCOS_BROAD
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 589 | 326 | 256 |
Only index persons | 521 | 296 | 225 |
Unadjusted period prevalence (%) | |||
Whole population | 0.01 | 0.01 | 0.01 |
Only index persons | 0.01 | 0.01 | 0.01 |
Median age at first event (years) | |||
Whole population | 57.31 | 57.45 | 57.21 |
Only index persons | 56.12 | 56.57 | 55.53 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 102 | 55 | 47 |
Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
Median age at first event (years) | 53.08 | 50.41 | 56.20 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 91
- Matched controls
- 907
LabWAS
↥Mortality – FinRegistry
↥Association
Association between endpoint E4_ADREMEDHYPER and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
E4_ADREMEDHYPER | 2.134 [1.49, 3.05] | < 0.001 |
Birth year | 0.993 [0.98, 1.0] | 0.122 |
During the follow-up period (1.1.1998 — 31.12.2019), 66 out of 254 females with E4_ADREMEDHYPER died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have E4_ADREMEDHYPER.N-year risk | Females | Males |
---|---|---|
1 | 0.217% | No data |
5 | 1.264% | No data |
10 | 2.879% | No data |
15 | 5.587% | No data |
20 | 9.629% | No data |
Relationships between endpoints
↥Index endpoint: E4_ADREMEDHYPER – Adrenomedullary hyperfunction
GWS hits: -